News

Home » NewsPage 2

Qu Biologics to Present in Victoria, Kamloops, Calgary and Edmonton

Crohn’s and Colitis Canada – Western Canada invites you to an evening of inspiration and learning.  Dr. Hal Gunn, immune system expert and founder of Qu Biologics will present “The Immune

Qu Biologics Presents Crohn’s Disease Compassionate Use Results at DDW

Vancouver, British Columbia – April 28, 2014 – Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to “reboot” the body’s immune system,

Qu Biologics Opens Crohn’s Disease Clinical Trial to U.S. Participants

Vancouver, British Columbia – February 18, 2014 – Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to “reboot” the body’s innate

FREE SEMINAR: Microbial involvement in Crohn’s disease

Qu Biologics is pleased to welcome microbiology expert Dr. Brian Coombes to Vancouver to give a seminar on his recently published research in Nature Communications demonstrating that infection of

Gastroenterology Panel Discussion about the use of SSIs for Crohn’s disease

Listen to this informative panel discussion about the use of site specific immunomodulators (SSIs), an investigational treatment aimed at stimulating the immune system to reverse the chronic

Podcast: The Natural Health Show Special Report on Crohn’s December 7th & 8th

Update December 10th - Podcast of the show now available. Listen here. ______ Tune into The Natural Health Show this weekend for a special report on the impact of Crohn's disease. Host Steve

Travel Subsidy Now Offered to Crohn’s Trial Participants

Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to “reboot” the body’s immune system, announced that it has received ethics approval to

First Patient Enrolled in Phase 1/2 Crohn’s Clinical Trial

Vancouver, British Columbia – June 11, 2013 – Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to “reboot” the body’s immune system,

New IBD Advisory Team Formed

Vancouver, British Columbia – May 30, 2013 – Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to “reboot” the body’s innate immune

Qu Biologics launches treatment trial for Crohn’s disease

Vancouver, BC – Canadian participants are being sought for a new Health Canada-approved clinical trial for the treatment of Crohn’s disease, the Vancouver-based biopharmaceutical company Qu

2/212